Welcome to the e-CCO Library!

P036: Human peripheral blood monocytes and intestinal macrophage populations activate transforming growth factor beta via expression of the integrin alpha v beta 8
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Shuttleworth E.*1,2,3, Kelly A.1,2,3, Fenton T.1,2,3, Smedley C.1,2,3, Levison S.4, Travis M.1,2,3

Created: Wednesday, 20 February 2019, 10:36 AM
P036: Identification and functional analysis of stromal subsets in experimental IBD mouse models
Year: 2022
Source: ECCO'22
Authors: Zhou, Z.(1);Plug, L.G.(1);de Jonge-Muller, E.S.M.(1);van de Beek, L.M.(1);Brands, L.(1);van der Meulen-de Jong, A.E.(1);Hawinkels, L.J.A.C.(1);Barnhoorn, M.C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P036: MicroRNA composition of colon crypt-top and crypt-bottom epithelial cells in Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Inčiūraitė, R.(1);Juzėnas, S.(1,2);Ramonaitė, R.(1);Skiecevičienė, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P037 Antagonism of chemokine receptor CCR9 synergises with anti-TNFα immunotherapy to reduce inflammation in the MDR1a−/− mouse model of colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Campbell1, L. Ertl1, K. Ebsworth1, J. McMahon2, P. Zhang2, V. Chhina1, I. Charo1, T. Schall1

Created: Thursday, 30 January 2020, 10:12 AM
P0370: Transmural healing in Ulcerative Colitis patients improves long-term outcomes compared to endoscopic healing alone
Year: 2025
Source: ECCO'25
Authors: Limx7x7x7 C.T.(1x7x7x72)*;Teichertx7x7x7 C.(2);Pruijtx7x7x7 M.(2);de Voogdx7x7x7 F.(2);D'Haensx7x7x7 G.(2);Gecsex7x7x7 K.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0371: Building a Robust Artificial Intelligence Solution for Use in Ulcerative Colitis Clinical Trials
Year: 2025
Source: ECCO'25
Authors: Byrnex7x7x7 M.(1x7x7x72)*;Requax7x7x7 J.(2);Panésx7x7x7 J.(3);Bresslerx7x7x7 B.(4);Panaccionex7x7x7 R.(5);Mendelx7x7x7 R.(2);Eastx7x7x7 J.E.(6);Parsax7x7x7 N.(2x7x7x77);Banerjeex7x7x7 R.(8);Kalapalax7x7x7 R.(8);Reddyx7x7x7 D.N.(8);Rughwanix7x7x7 H.R.(8);Fleggx7x7x7 D.(9);Moranx7x7x7 G.(10);Gallingerx7x7x7 Z.(11);Cheungx7x7x7 V.(6);Tanx7x7x7 M.(12);Max7x7x7 C.(5);Travisx7x7x7 S.P.(6);Jairathx7x7x7 V.(13);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0372: Fatigue in Swedish patients with Inflammatory bowel disease
Year: 2025
Source: ECCO'25
Authors: Jäghultx7x7x7 S.(1)*;Pilhl Lesnovskax7x7x7 K.(2);Marsalx7x7x7 J.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0373: CLINICAL RECURRENCE AFTER ILEOCOLIC RESECTION FOR CROHN'S DISEASE: Interest of the REMIND group's endoscopic score
Year: 2025
Source: ECCO'25
Authors: Amalx7x7x7 J.(1)*;Abdelwahabx7x7x7 N.(1);Soniax7x7x7 B.(1);myriamx7x7x7 A.(2);zeinebx7x7x7 B.(1);nessrinex7x7x7 H.(1);bochrax7x7x7 B.(1);taiebx7x7x7 J.(2);rymx7x7x7 E.(1);Med Hedix7x7x7 D.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0374: Prevalencex7x7x7 risk factors and clinical outcomes of malignancies in patients with Inflammatory Bowel Disease: a case-control study
Year: 2025
Source: ECCO'25
Authors: Foteinogiannopouloux7x7x7 K.(1)*;Nikolaoux7x7x7 P.(2);Orfanoudakix7x7x7 E.(1);Theodorakix7x7x7 E.(1);Theodoropouloux7x7x7 A.(2);Karmirisx7x7x7 K.(2);Koutroubakisx7x7x7 I.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0375: Fibromyalgia as a predictive factor of fatigue and reduced quality of life in patients with inflammatory bowel disease.
Year: 2025
Source: ECCO'25
Authors: Prado x7x7x7 R.D.C.P.(1);Domiciano x7x7x7 D.S.(2);Mattos x7x7x7 P.S.L.D.(1);Linhares x7x7x7 F.D.S.(1);Azevedo x7x7x7 M.F.C.D.(1);Carlos x7x7x7 A.D.S.(1);Damião x7x7x7 A.O.M.C.(1);Barros x7x7x7 L.L.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0376: Advancing intestinal ultrasound for IBD in Turkey: results of a national survey.
Year: 2025
Source: ECCO'25
Authors: Bilicanx7x7x7 G.(1);Karakanx7x7x7 T.(1);Eğritaş Gürkanx7x7x7 Ö.(2);Sabhanx7x7x7 H.(3);Hedinx7x7x7 C.(4);Forssx7x7x7 A.(5);Petrousisx7x7x7 G.(6);Cindorukx7x7x7 M.(1);Canx7x7x7 A.(2);Haasx7x7x7 S.L.(6x7x7x77)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0377: Development of Crohn's Aid mobile application based on AI algorithms to make an early diagnosis of Crohns Disease in TB endemic regions
Year: 2025
Source: ECCO'25
Authors: Mohtax7x7x7 S.(1)*;Kutumx7x7x7 R.(2);Pendyalax7x7x7 R.(2);Devx7x7x7 H.(2);Kantex7x7x7 B.(1);Kumar Vuyyurux7x7x7 S.(1);Kumarx7x7x7 P.(1);Virmanix7x7x7 S.(1);Kumarx7x7x7 M.(1);Bahlx7x7x7 S.(1);Makhariax7x7x7 G.(1);Chaudhuryx7x7x7 S.(3);Kediax7x7x7 S.(1);Sethix7x7x7 T.(2);Ahujax7x7x7 V.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0378: Normalization or reduction of at least 50% in faecal calprotectin levels after 3 months of treatment predicts clinical and endoscopic remission at 1 year in patients with ulcerative colitis: results of the prospective MIROIR study
Year: 2025
Source: ECCO'25
Authors: Buissonx7x7x7 A.(1)*;Cobanx7x7x7 D.(1);Bazogex7x7x7 M.(1);Dodelx7x7x7 M.(1);Pereirax7x7x7 B.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0379: Characteristics of histologically confirmed upper gastrointestinal lesions in patients with Crohn's disease in Korea
Year: 2025
Source: ECCO'25
Authors: Nax7x7x7 S.Y.(1)*;Jix7x7x7 J.S.(1);Choix7x7x7 H.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P037: Bacterial handling defect in macrophages of patients with defects in glucose-6-phosphate metabolism and Crohn’s disease like intestinal inflammation
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Pandey1*, K. Balagopal1, D. Aschenbrenner1, M. Capitani1, C. Weidinger2, E. Pires3, J. McCullagh3, S. Travis1, J. Ziegler2, B. Siegmund2, H.H. Uhlig1

Created: Thursday, 21 February 2019, 9:14 AM
P037: Enhancing the efficacy of cannabidiol using protein nanoparticles to treat inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Moniruzzaman, M.(1,2)*;Rewatkar, P.(1);Begun, J.(2);Popat, A.(1);
Created: Friday, 14 July 2023, 10:48 AM
P037: MDR1-deficiency unmasks mitochondrial dysfunction as a pathogenic mechanism in IBD
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ho G.-T.*1, Aird R.1, Boyapati R.1, Liu B.2, Kennedy N.1, Shimizu T.3, Sartor B.2, Satsangi J.1

Created: Wednesday, 20 February 2019, 10:36 AM
P037: MicroRNA-31 and microRNA-200 family reflect disease activity in Crohn’s disease: results from the BIOMIR study
Year: 2022
Source: ECCO'22
Authors: Cristina, T.(1);Mateescu, B.(2);Mitroi, A.(3);Cozaru, G.(3);Brinzan, C.(3);State, M.(2);Dumitru, A.(1);Rafti, R.(1);Dina, E.(1);Alexandrescu, L.(1);Dumitru, E.(1);
Created: Friday, 11 February 2022, 3:52 PM
P037: Nonclinical pharmacokinetics and absorption, distribution, metabolism, and excretion properties of MORF-057 support its clinical development as an oral selective α4β7 integrin inhibitor
Year: 2021
Source: ECCO'21 Virtual
Authors: Jones, J.(1);Lee, D.(1);Smukste, I.(1);Cui, D.(1);Bursavich, M.G.(2);Troast, D.(2);Zhong, C.(2);Wong , J.E.(3);Mangada, M.M.(3);Bain, G.(3);Lippa, B.(2);Ray, A.S.(3);Rogers, B.N.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P037: Remodelling events preceding clinical onset of intestinal inflammation reveal the predictive power of the extracellular matrix
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

E. Shimshoni*1, R. Afik1, L. Puricelli2, A. Shenoy3, T. Geiger3, A. Podestà2, I. Sagi1

Created: Friday, 22 February 2019, 9:49 AM